{
  "meta": {
    "title": "Neet_Pg_2023",
    "url": "https://brainandscalpel.vercel.app/neet-pg-2023-0692a30c.html",
    "scrapedAt": "2025-11-30T07:36:15.806Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Sacubitril </span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Omapatrilat </span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image depicts the synthesis pathway of angiotensin II and the role of neprilysin, with arrows pointing to the ACE and neprilysin enzymes. Which drug exerts its action by inhibiting both of these enzymes?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508088DB3.png\"></span></p>",
      "unique_key": "DT1323780",
      "question_audio": null,
      "question_video": null,
      "map_id": 1323780,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Omapatrilat </strong>is a dual inhibitor of <strong>Neprilysin </strong>and<strong> Angiotensin-Converting Enzyme (ACE), </strong>as mentioned above.</p>\r\n<ul>\r\n<li>This dual inhibition leads to increased levels of bradykinin, a peptide that can cause vasodilation and increased vascular permeability.</li>\r\n<li>The accumulation of bradykinin is associated with a higher risk of severe angioedema, which is a serious and potentially life-threatening side effect.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508086CE8.png\">\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Sacubitril (Option A) </strong>is an ARNI (Angiotensin Receptor-Neprilysin Inhibitor) used in heart failure with reduced ejection fraction (HFrEF), having side effects such as hypotension, hyperkalemia, renal impairment, and angioedema.</p>\r\n<p><strong>Losartan (Option C) </strong>is an Angiotensin Receptor Blocker (ARB) that functions as a competitive antagonist and inverse agonist at AT1 receptors. Additionally, it has an antiplatelet effect by blocking thromboxane A2 receptors and demonstrates uricosuric properties, which could be advantageous for managing gout.</p>\r\n<p><strong>Nesiritide (Option D) </strong>is a recombinant human BNP (B-type Natriuretic Peptide) that acts by increasing the levels of cyclic GMP, promoting vasodilation and natriuresis. It does not act on RAAS or NEP pathways.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Clotrimazole </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Griseofulvin </span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Terbinafine </span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Flucytosine </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with bronchial asthma on inhaled corticosteroids presents with white, patchy lesions on the tongue and buccal mucosa. Which medication is appropriate for treating this condition?</span></p>",
      "unique_key": "DT1324433",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The condition characterised by patchy lesions on the tongue and buccal mucosa resulting from the use of inhaled steroids is oral thrush, which can be treated with <strong>Clotrimazole</strong>.</p>\n<ul>\n<li>Clotrimazole is a topical antifungal medication (imidazole) that effectively penetrates the skin layers to treat superficial fungal infections.</li>\n<li><strong><strong>Mechanism of action: </strong>Inhibits the 14 alpha demethylase enzyme (CYP), which converts lanosterol into ergosterol cell membrane, hence decreasing cell membrane synthesis.</strong></li>\n<li>All azoles are metabolised by the CYP2C19 enzyme.</li>\n<li>It is commonly used in the treatment of conditions such as oral thrush, tinea, and candidiasis.</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Griseofulvin (Option B) </strong>acts by inhibiting microtubules within fungal cells, thereby disrupting mitosis. It is the drug of choice for superficial fungal infections, such as tinea. However, it can cause side effects, including headache, neuritis, hepatitis, photosensitivity, and a disulfiram-like reaction.</p>\n<p><strong>Terbinafine (Option C)</strong> is an allylamine antifungal that inhibits squalene epoxidase, reducing ergosterol synthesis and disrupting cell membrane integrity. It is the drug of choice for onychomycosis (fungal nail infections), tinea capitis (scalp ringworm), and extensive fungal lesions.</p>\n<p><strong>Flucytosine (Option D) </strong>acts as an inhibitor of thymidylate synthase and is a narrow-spectrum fungistatic agent effective against Cryptococcus neoformans and chromoblastomycosis.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost </span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin </span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone </span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Methyl ergometrine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which drug is contraindicated in patients with asthma when managing postpartum haemorrhage?</span></p>",
      "unique_key": "DT1324438",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Carboprost</strong> is contraindicated in women with asthma when treating postpartum haemorrhage.</p>\r\n<ul>\r\n<li>A derivative of prostaglandin F2&alpha; and the correct dosage for managing PPH is 250 &mu;g IM, repeated every 15-90 minutes, up to 8 doses.</li>\r\n<li><strong>Side effects:</strong> Diarrhoea, hypertension, vomiting, fever, flushing, tachycardia</li>\r\n<li><strong>Contraindications:</strong> asthma, pulmonary hypertension, suspected amniotic fluid embolism, and certain renal, liver, and cardiac conditions.</li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Oxytocin (Option B) </strong>is a hormone secreted by the posterior pituitary alongside arginine vasopressin. It is the drug of choice for managing postpartum haemorrhage.</p>\r\n<p><strong>Dinoprostone (Option C)</strong> is a prostaglandin E2 analogue (PGE2) and the drug of choice for cervical ripening (vaginal use). It is also utilised for labour induction and medical abortion.</p>\r\n<p><strong>Methyl ergometrine (Option D) </strong>is an ergot alkaloid that acts on the myometrium, inducing strong and frequent uterine contractions, which lead to uterine spasms. It is used in the management of postpartum haemorrhage.</p>\r\n<p><strong>Key Takeaways</strong><strong>:</strong></p>\r\n<p><strong>Postpartum haemorrhage (PPH)</strong></p>\r\n<ul>\r\n<li>Life-threatening childbirth complications require prompt management.</li>\r\n<li>Pharmacological intervention is often necessary to control bleeding</li>\r\n<li>Indicated drugs include oxytocin, misoprostol, methylergonovine, and tranexamic acid, but carboprost is contraindicated in bronchial asthma.</li>\r\n<li><strong><strong>Contraindicated drugs: </strong>Prostaglandin E1 analogues (e.g., alprostadil, epoprostenol) due to severe hypotension risk, and ergotamine derivatives (e.g., ergonovine, methylergometrine) in hypertension/pre-eclampsia due to hypertension risk.</strong></li>\r\n</ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone </span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol </span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin </span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a history of myocardial infarction and ventricular arrhythmias has been on long-term treatment. He now presents with fatigue, shortness of breath, weight gain, and signs of pulmonary fibrosis. Which medication is most likely responsible for these findings?</span></p>",
      "unique_key": "DT1324442",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Amiodarone</strong>, a potassium channel blocker and class 3 anti-arrhythmic drug, is used to treat both atrial and ventricular fibrillation. It may cause side effects such as fatigue, dyspnea, weight gain, and, with prolonged use, pulmonary fibrosis.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250808C9B7.png\">\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Atenolol (Option B)</strong> is a beta-blocker used for managing hypertension, stable heart failure, post-myocardial infarction (to prevent sudden cardiac death), and the prevention of left ventricular hypertrophy. Side effects include fatigue, reduced libido, cognitive issues, nightmares, bradycardia, hypotension, rebound hypertension, aggravated ischemia, angina, MI, and increased triglycerides/LDL.</p>\r\n<p><strong>Aspirin (Option C)</strong> is an antiplatelet medication that irreversibly inhibits COX-1, thereby preventing platelet aggregation. It is the drug of choice for myocardial infarction (MI), stroke, and Buerger's disease.</p>\r\n<p><strong>Spironolactone (Option D) </strong>is a potassium-sparing diuretic that either inhibits sodium channels in the distal nephron or blocks aldosterone receptors. It is used to treat heart failure and hyperaldosteronism. Side effects include hyperkalemia and gynecomastia.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">N-acetyl cysteine to replenish glutathione stores</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Pralidoxime </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon to control bradycardia and hypoglycemia </span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Give sodium bicarbonate to alkalize urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman presents to the emergency department after ingesting approximately 100 aspirin tablets. What is the most appropriate next step in her management? </span></p>",
      "unique_key": "DT1324452",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324452,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The given scenario is a case of <strong>aspirin toxicity</strong> in which the primary treatment is to give <strong>sodium bicarbonate</strong> to alkalize the urine.</p>\r\n<ul>\r\n<li>It is an antiplatelet medication that irreversibly inhibits COX-1, thereby preventing platelet aggregation.</li>\r\n<li>Aspirin stimulates the brain's respiratory centre, causing hyperventilation (&darr;CO2 levels) and <strong>respiratory alkalosis.</strong></li>\r\n<li>The kidneys excrete more bicarbonate to counteract respiratory alkalosis, resulting in <strong>compensatory metabolic acidosis.</strong> High doses of aspirin can disrupt oxidative phosphorylation and kidney function, exacerbating metabolic acidosis.</li>\r\n</ul>\r\n<p><strong>Dosage and Toxicity:</strong></p>\r\n<ul>\r\n<li><strong>Therapeutic Dose: </strong>3-5 g/day can cause <strong>mild chronic toxicity (salicylism).</strong></li>\r\n<li>Toxic Dose: Acute ingestion of 10-30 g in adults can be lethal, with much lower doses (4 mL of methyl salicylate) posing a significant risk in children</li>\r\n</ul>\r\n<p><strong>Clinical presentation:</strong></p>\r\n<ul>\r\n<li><strong><strong>Salicylism: </strong>Headache, dizziness, tinnitus, <strong>reversible hearing and vision impairment, </strong>drowsiness, vomiting, hyperventilation, electrolyte imbalance</strong></li>\r\n<li>Severe toxicity: Dehydration, high tone deafness, confusion, petechial haemorrhages, hyperpyrexia, seizures, hypoglycemia, psychosis, coma</li>\r\n</ul>\r\n<p><strong>Management:</strong> Treatment is supportive and includes gastric lavage, correction of metabolic acidosis, vitamin K supplements and urinary alkalinisation with intravenous sodium bicarbonate to enhance salicylate excretion. In severe cases, hemodialysis may be necessary.</p><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025080833E4.png\">\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>N-acetyl cysteine to replenish glutathione stores (Option A) </strong>is not indicated in the management of aspirin overdose. It is used as an antidote for acetaminophen overdose, which can cause liver toxicity by depleting glutathione stores. Aspirin overdose does not cause glutathione depletion, so N-acetylcysteine is not useful in this situation.</p>\r\n<p><strong>Pralidoxime (Option B) </strong>is not indicated in the management of aspirin overdose. Pralidoxime is an antidote for organophosphate poisoning, which can cause cholinergic toxicity by inhibiting acetylcholinesterase activity. Aspirin overdose does not cause cholinergic toxicity, so this option is not used here.</p>\r\n<p><strong>Glucagon to control bradycardia and hypoglycemia (Option C): </strong>Glucagon is not indicated in the management of aspirin overdose. Glucagon is used as an antidote to beta-blocker toxicity.</p>\r\n<p><strong>Key Takeaways</strong><strong>:</strong></p>\r\n<ul>\r\n<li>High-dose aspirin causes respiratory alkalosis (stimulates the brain's respiratory centre) &amp; metabolic acidosis (Increases bicarbonate excretion and disrupts oxidative phosphorylation)</li>\r\n<li>Management of aspirin toxicity: Urinary alkalinisation with intravenous sodium bicarbonate and vitamin K supplements, and in severe cases, hemodialysis may be necessary.</li>\r\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor downregulation </span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Rebound hypertension </span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Receptor hypersensitivity </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker undergoing nicotine replacement therapy was also prescribed clonidine for smoking cessation. After abruptly discontinuing clonidine, he developed a headache. What is the most likely explanation for this symptom?</span></p>",
      "unique_key": "DT1324457",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In the given scenario, the patient stopped taking clonidine tablets and now presents with a headache (a common symptom of rebound hypertension). <strong>Discontinuation of clonidine </strong>can cause<strong> rebound hypertension</strong> due to decreased<strong> alpha-2 adrenergic receptor activity, </strong>leading to increased sympathetic outflow and a subsequent rise in blood pressure.</p>\r\n<p><strong>Clonidine:</strong></p>\r\n<ul>\r\n<li>It is a centrally acting alpha-2 adrenergic receptor agonist commonly used to manage <strong>hypertension, opioid withdrawal, and smoking cessation. </strong></li>\r\n<li>When used for smoking cessation, it helps to reduce the withdrawal symptoms associated with nicotine addiction, such as cravings, anxiety, and irritability.</li>\r\n<li>One of the side effects of clonidine therapy is<strong> rebound hypertensio</strong>n, which can occur when the drug is abruptly discontinued as alpha 1 receptors are upregulated.</li>\r\n<li>Rebound hypertension is characterised by a sudden and significant increase in blood pressure, which can cause symptoms such as headache, dizziness, and confusion.</li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Postural hypotension (Option A) </strong>is characterised by a sudden drop in blood pressure upon standing up, which <strong>can cause dizziness and fainting</strong>. This is not the cause of the headache in this scenario, as per the patient&rsquo;s symptoms.</p>\r\n<p><strong>Receptor downregulation (Option B) </strong>is a phenomenon in which the number of receptors on the cell surface decreases in response to an increase in the stimulation of receptors. This is not the cause of the headache in this scenario, as the upregulation of receptors leads to rebound hypertension.</p>\r\n<p><strong>Receptor hypersensitivity (Option C) </strong>is a condition in which the receptors on the cell surface become more sensitive to the ligand, which can result in an exaggerated response to the drug. This is not the cause of the headache in this scenario, as hypersensitivity of the receptors would not result in rebound hypertension or headache.</p>\r\n<p><strong>Key Takeaways:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250808D74C.png\">",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin (IL-11)</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim </span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin </span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Amifostine </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A cancer patient receiving chemotherapy experienced a drop in platelet count during the previous treatment cycle. At what point should intervention be administered to prevent or manage this condition in future cycles?</span></p>",
      "unique_key": "DT1324463",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324463,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Oprelvekin (IL-11) </strong>is a medication used to stimulate platelet production in patients who have undergone chemotherapy.</p>\r\n<ul>\r\n<li>It works by stimulating the production of megakaryocytes, which are the cells that produce platelets.</li>\r\n<li>It is approved for use in patients with <strong>chemotherapy-induced thrombocytopenia (CIT)</strong>, a condition characterised by a low platelet count caused by chemotherapy.</li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Filgrastim (Option B) </strong>is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. It works by stimulating the bone marrow to produce more white blood cells, which can help to prevent infections. While low platelet counts can be a side effect of chemotherapy, filgrastim is not indicated for treating thrombocytopenia.</p>\r\n<p><strong>Erythropoietin (Option C) </strong>is a medication that stimulates red blood cell production in patients with anaemia. It is not indicated for the treatment of thrombocytopenia.</p>\r\n<p><strong>Amifostine (Option D) </strong>is a medication used to protect healthy cells from the toxic effects of chemotherapy. It does not stimulate the production of platelets and is not indicated for the treatment of thrombocytopenia.</p>\r\n<p><strong>Key Takeaways</strong><strong>:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508080FBE.png\">",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">The telmisartan dose should be reduced in renal failure but not in hepatic failure. </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">The irbesartan dose should be reduced in case of mild to moderate hepatic failure and renal failure</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Candesartan dose should be reduced in mild to moderate liver failure, but not in renal failure.</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan acts as a thromboxane A2 antagonist and inhibits platelet aggregation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is correct?</span></p>",
      "unique_key": "DT1324469",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324469,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Losartan</strong> is an angiotensin II receptor antagonist that blocks the binding of angiotensin II to the AT1 receptor subtype, leading to the dilation of blood vessels and reduced blood pressure.</p>\r\n<ul>\r\n<li>It also blocks thromboxane A2 receptors and has some platelet antiaggregatory properties.</li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Telmisartan dose should be reduced in renal failure but not in hepatic failure (Option A): </strong>Telmisartan is primarily eliminated by the liver and metabolised by the cytochrome P450 system. In case of hepatic impairment, the dose of telmisartan should be reduced. The dose does not need to be reduced in renal failure.</p>\r\n<p><strong>Irbesartan dose should be reduced in case of mild to moderate hepatic failure and renal failure (Option B): </strong>Irbesartan is metabolised by the liver and excreted by the kidneys. In case of mild to moderate hepatic impairment or renal impairment, the dose should be reduced.</p>\r\n<p><strong>Candesartan dose should be reduced in mild to moderate liver failure, but not in renal failure (Option C): </strong>Candesartan is mainly eliminated through the liver and excreted through the bile. In case of mild to moderate liver failure, the dose of candesartan should be reduced, but no dose adjustment is required in renal failure.</p><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508084A2F.png\">",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">40 hours</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">80 hours </span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">120 hours </span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">140-180 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient receiving digoxin develops side effects such as nausea and vomiting. His serum digoxin concentration is found to be 4 ng/mL, while the therapeutic range is up to 1 ng/mL. Given that digoxin has a half-life of 40 hours, how long will it take before the drug can be safely restarted?</span></p>",
      "unique_key": "DT1324475",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324475,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>It will take<strong> 80 hours</strong> before the drug can be safely restarted.</p>\r\n<p>The Plasma half-life (t&frac12;) of a drug is the time taken for its plasma concentration to be <strong>reduced to half of its original value.</strong></p>\r\n<ul>\r\n<li>In the scenario, the digoxin serum concentration of 4 ng/ml is significantly above the therapeutic range.</li>\r\n</ul>\r\n<p>Starting at <strong>4 ng/mL</strong>, it would take:</p>\r\n<ul>\r\n<li>1 half-life (40 hrs) &rarr; 2 ng/mL</li>\r\n<li>2 half-lives (80 hrs) &rarr; 1 ng/mL (within therapeutic range)</li>\r\n</ul>\r\n<p>Since the <strong>therapeutic range is &le;1 ng/mL</strong>, the drug can be safely restarted after <strong>80 hours</strong>.</p>\r\n<ul>\r\n<li>Therefore, we should wait at least <strong>80 hours </strong>before resuming treatment, considering digoxin's half-life of 40 hours.</li>\r\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine toxicity</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">A side effect of pralidoxime</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to organophosphate poisoning</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents to the emergency department following organophosphate compound poisoning and is treated with intravenous atropine infusion and pralidoxime. Two hours later, the patient develops a sudden rise in body temperature. What is the most likely cause of the fever?</span></p>",
      "unique_key": "DT1324476",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324476,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The scenario described involves <strong>organophosphate (OP) poisoning</strong>, for which <strong>atropine</strong> and <strong>pralidoxime</strong> are used as treatment. The sudden onset of fever, in this case, is most likely a result of <strong>Atropine</strong> toxicity.</p>\r\n<ul>\r\n<li>Atropine works by blocking the action of acetylcholine at muscarinic receptors in the body.</li>\r\n<li>It also has other effects on the body, such as increased heart rate, pupil dilation, and dry secretions. These effects can lead to a rise in body temperature, which is known as <strong>atropine fever.</strong></li>\r\n<li>It is the <strong>drug of choice (DOC) for OPC and carbamate poisoning, bradycardia and AV block</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>A side effect of pralidoxime (Option B):</strong> Pralidoxime, on the other hand, is used to reactivate acetylcholinesterase, the enzyme that is inhibited by organophosphate poisoning. It can cause side effects such as headache, dizziness, and blurred vision, but it is unlikely to cause fever.</p>\r\n<p><strong>Due to organophosphate poisoning (Option C): </strong>Organophosphate poisoning can cause a range of symptoms such as muscle weakness, respiratory distress, and seizures, but it is not typically associated with fever.</p>\r\n<p><strong>Idiopathic (Option D): </strong>Idiopathic fever refers to a fever of unknown cause, which is not the case in this scenario, as the cause of the fever is likely related to atropine toxicity.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibit the extrinsic pathway </span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits platelet aggregation</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Enhance fibrin degradation </span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibit clot formation </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the mechanism of action of tissue plasminogen activator (tPA)?</span></p>",
      "unique_key": "DT1324478",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324478,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Tissue plasminogen activator (tPA)</strong> is a naturally occurring enzyme that converts plasminogen to plasmin. Plasmin is responsible for <strong>breaking down fibrin clots</strong> in the blood, which is the mechanism of action of tPA.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508086CD3.png\">\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Inhibit extrinsic pathway (Option A): </strong>Tissue factor pathway inhibitor (TFPI) is the inhibitor of the extrinsic pathway of coagulation. It inhibits the formation of factor Xa and thus prevents thrombin formation.</p>\r\n<p><strong>Inhibits platelet aggregation (Option B): </strong>Antiplatelet agents like aspirin and clopidogrel inhibit platelet aggregation and prevent the formation of blood clots.</p>\r\n<p><strong>Inhibit clot formation (Option D): </strong>Anticoagulant drugs like heparin and warfarin inhibit the formation of blood clots by interfering with the coagulation cascade at different points. They do not directly break down existing clots.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethacrynic acid</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol </span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Bumetanide </span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was started on dialysis, and he developed disequilibrium. Which of the following drugs should be started? </span></p>",
      "unique_key": "DT1324482",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Mannitol</strong> is used in the treatment of dialysis disequilibrium syndrome.</p>\r\n<ul>\r\n<li>Excessively removing solutes from the extracellular fluid by hemodialysis results in a reduction in the osmolality of extracellular fluid. Consequently, water moves from the extracellular compartment into the intracellular compartment, causing hypotension and CNS symptoms (headache, nausea, muscle cramps, restlessness, CNS depression, and convulsions).</li>\r\n<li>Osmotic diuretics increase the osmolality of the extracellular fluid compartment and thereby shift water back into the extracellular compartment.</li>\r\n</ul>\r\n<p><strong>Mannitol </strong>is an osmotic diuretic that acts by increasing the osmolarity of the glomerular filtrate, inhibiting water reabsorption.</p>\r\n<ul>\r\n<li><strong>Use: </strong>Cerebral edema, acute glaucoma, and dialysis disequilibrium syndrome.</li>\r\n<li><strong>Side effects: </strong>Dehydration, electrolyte imbalance.</li>\r\n</ul>\r\n<p><strong>Ethacrynic acid (Option A) </strong>and <strong>Bumetanide (Option C) </strong>are loop diuretics that<strong> inhibit the Na-K-2Cl symporter in the thick ascending loop of Henle.</strong> They are used in cases of acute pulmonary edema, chronic heart failure, and hypercalcemia.</p>\r\n<p><strong>Nesiritide (Option D) </strong>is a recombinant human BNP (B-type Natriuretic Peptide), acts by<strong> increasing the levels of cyclic GMP,</strong> promoting vasodilation and natriuresis. It does not act on RAAS or NEP pathways.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Datura - PAM</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Datura - Physostigmine</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow oleander - Digibind</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow oleander - Physostigmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with abnormal behaviour, fever, and reduced urine output following the consumption of an unidentified fruit. What is the likely causative factor, and what is the appropriate treatment?</span></p>",
      "unique_key": "DT1324490",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324490,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation: </strong></p>\r\n<p>The scenario involves a child who consumed an unknown fruit and subsequently developed fever and decreased urine output, suggesting <strong>Datura Poisoning</strong>. The antidote for this condition is <strong>physostigmine.</strong></p>\r\n<ul>\r\n<li>Datura contains <strong>hyoscine (scopolamine), hyoscyamine and traces of atropine </strong></li>\r\n<li><strong>Mechanism of Action: </strong>Initially, it stimulates the higher centres of the brain and then activates the motor centres. Later, it leads to depression of the vital centres in the medulla, resulting in paralysis.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250808E7C1.png\">\r\n<ul>\r\n<li><strong><strong>Clinical features:</strong></strong></li>\r\n</ul>\r\n<ul>\r\n<ul>\r\n<li>Dryness of the mouth and throat</li>\r\n<li>Dysphagia</li>\r\n<li>Difficulty in talking</li>\r\n<li>Hoarseness of voice</li>\r\n<li>Flushed face</li>\r\n<li>Pupil dilatation</li>\r\n<li>Photophobia + Diplopia</li>\r\n<li>Agitation and restlessness</li>\r\n<li>Delirium</li>\r\n<li>Urinary retention</li>\r\n<li>Dry and hot skin</li>\r\n<li>Exfoliation of the skin may occur</li>\r\n</ul>\r\n<li>Patients can end up in a coma, or death can occur due to <strong>respiratory paralysis.</strong></li>\r\n<li>Treatment</li>\r\n<ul>\r\n<li><strong>Gastrointestinal decontamination: </strong>Administer <strong>activated charcoal</strong> to absorb toxins. Use a cathartic if indicated.</li>\r\n<li><strong>Antidote: </strong>Administer <strong>Physostigmine 1-2 mg IV slowl</strong>y, repeating as necessary based on symptom response.</li>\r\n<li><strong>Symptomatic treatment: </strong>Consider <strong>Pilocarpine 5 mg</strong> subcutaneously for severe anticholinergic effects.</li>\r\n<li><strong>Supportive care: </strong>Monitor vital signs and address any respiratory or cardiovascular issues.</li>\r\n</ul>\r\n</ul>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Aripiprazole </span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Brexpiprazole </span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Ziprasidone </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient being treated with haloperidol and thioridazine shows inadequate response. A new medication is added, after which the patient develops hyperglycemia, weight gain, and excessive salivation. Which drug was most likely introduced?</span></p>",
      "unique_key": "DT1324495",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324495,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Clozapine</strong> is prescribed for treatment-resistant schizophrenia and is particularly effective in patients who do not respond to other antipsychotic medications. However, it is associated with increased appetite (<strong>blocking the 5-HT2C receptor</strong>), which can lead to weight gain, hyperglycemia, and abnormal lipid levels.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508083B2D.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250808B19F.png\">\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Aripiprazole (Option B) </strong>is an atypical antipsychotic approved for schizophrenia, autism in children under 7 years old, and unipolar depression. It can also treat acute mania and is used for maintenance treatment in bipolar disorder, and is associated with the least weight gain.</p>\n<p><strong>Brexpiprazole (Option C) </strong>is a derivative of aripiprazole, approved for schizophrenia and adjunctive depression treatment, with lower D2 receptor agonist efficacy and stronger 5HT1A partial agonist effects.</p>\n<p><strong>Ziprasidone (Option D) </strong>is an antipsychotic with low weight gain risk, extremely high 5HT2c affinity, and poor affinity for H1 histamine receptors.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefazolin </span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin </span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillin </span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which antibiotics are recommended for use as prophylaxis during procedures performed on patients with underlying cardiac conditions?</span></p>",
      "unique_key": "DT1324497",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Cefazolin</strong> is the antibiotic of choice for procedures involving cardiac patients.</p>\r\n<ul>\r\n<li>It is a first-generation cephalosporin that can be useful against Streptococci, S. aureus, some Proteus, E. coli, and Klebsiella.</li>\r\n<li>It is the<strong> drug of choice for surgical prophylaxis.</strong></li>\r\n</ul>\r\n<p><strong>Explanation for other options:</strong></p>\r\n<p><strong>Azithromycin (Option B) </strong>is a macrolide that inhibits bacterial protein synthesis by binding to the <strong>50S ribosomal subunit</strong>, halting bacterial growth. It is used to treat respiratory Infections (e.g., pneumonia, bronchitis), genitourinary Infections (e.g., Chlamydia trachomatis), and infections like otitis media, pharyngitis, cellulitis, etc.</p>\r\n<p><strong>Penicillin (Option C)</strong> is a <strong>beta-lactam</strong> antibiotic that inhibits bacterial cell wall synthesis and is used to treat<strong> syphilis.</strong></p>\r\n<p><strong>Doxycycline (Option D) </strong>is a protein synthesis inhibitor (tetracycline) that blocks the <strong>30S mRNA-ribosome, </strong>thus inhibiting the attachment of <strong>aminoacyl-tRNA to the acceptor (A) site</strong>. It is used in infections like pleurodesis, H. pylori Infection, leprosy, plague, borrelia, etc.</p>\r\n<p><strong>Key Takeaways</strong><strong>:</strong></p>\r\n<p><strong>Classification of cephalosporins:</strong> They are classified into 5 generations.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202508087AC0.png\">",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}